查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年输液泵全球市场
市场调查报告书
商品编码
1140755

2022-2029 年输液泵全球市场

Global Infusion Pumps Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

慢性病的增加正在推动市场增长

在美国，每 10 人中就有 6 人患有慢性病，例如心臟病、癌症、中风和糖尿病。根据疾病控制与预防中心2022年发布的报告，美国约有3730万人患有糖尿病，约占美国人口的11.3%。其中，已确诊2870万人，其中成年人2850万人，成年人850万人（23.0%的成年人未确诊）。共有 9600 万 18 岁以上的人处于糖尿病前期，约占美国成年人口的 38%。 2640 万（48.8%）65 岁及以上的美国人处于糖尿病前期。糖尿病是美国第七大死亡原因。此外，冠心病是美国最常见的心臟病，据说2020年将有约382,820人死亡。大约 2010 万 20 岁以上的成年人患有冠心病（约 7.2%）。到 2020 年，约十分之二的 CAD 死亡将发生在 65 岁以下的成年人中。

但是，严格的法规、产品召回以及改进型输液泵的采用增加正在阻碍市场增长。例如，2020 年 3 月 6 日，BD 召回了 Alaris System 输液泵。根据 FDA 的说法，这被归类为 I 类召回，这是最严重的召回类型之一。使用这些设备可能会导致严重伤害或死亡。由于多个系统、软件和使用错误，BD/Care Fusion 303 召回了 Alaris 输液泵系统和模块。

地理渗透。

北美是预测期内的主要地区。

北美有很高的采用率来治疗慢性病的专用输液泵、慢性病患病率的增加、老年人口的增长以及该地区许多大型医院的存在。主导了全球市场并在2021年占据了最大的市场份额。加拿大大量的胰岛素治疗推动了北美药物输送输液系统市场。根据 Statista 的数据，到 2021 年，大约 7.3% 的加拿大人将报告有医疗保健提供者诊断出的糖尿病。主要注射和输液系统製造商的地域扩张正在推动北美输液泵市场。输液系统的推出一直是推动北美药物输送输液系统市场的关键因素。例如，2022 年 8 月，创新给药技术的领导者百特国际公司宣布美国食品药品监督管理局批准了带有 Dose IQ 安全软件的新型 Novum IQ 注射器输液泵 (SYR)，它代表了百特在输液疗法。这些注射器输液泵通常用于儿科、新生儿、麻醉和其他医疗环境，以低速和精确地输送少量液体。

竞争格局。

全球输液泵市场分散，有大量国际和地区参与者。市场上的主要参与者包括 B. Braun、Medtronic Plc、F. Hoffmann-La Roche Ltd.、Smiths Medical、Becton、Dickinson And Company、Baxter International Inc、Terumo Corporation、Teleflex, Inc、Mindray Medical International Limited、Fresenius Kabi 等。主要参与者正在采取各种增长战略，如业务扩张、併购、合作伙伴关係、产品发布、联盟等，为全球输液泵市场的增长做出贡献。例如，2020 年 2 月 27 日，LTR Medical 决定与 Woo Young Medical 签订独家分销协议，将其新一代弹性体注射技术分销到澳大利亚市场。 Woo Young Medical 是全球动态输液技术的领导者之一，总部位于韩国。图为 LTR Medical 首席执行官 Lee Rodne 和 Woo Young Medical 首席运营官兼总裁 Brian Cha。 2020 年 2 月 24 日，Unity Therapeutics Corporation 和 DEKA Research & Development Corp. 发布了 FDA（美国食品和药物管理局）510(k) 用于 Remodulin（曲前列素）注射液的 Unity 皮下给药系统，称为 Remunity(TM) 泵. 该批准允许 United Therapeutics 推出该系统，该□□系统带有来自专业药房的预装药罐。 2020年1月，美敦力还为其鞘内给药系统“Syncromed II”推出了基于云的数据管理软件“Efficio”。它使临床医生能够有效地管理有针对性的药物输送泵实践，以治疗患有慢性疼痛、癌症和严重痉挛的患者。

全球输液泵市场报告提供对大约 44 个市场数据表、43 个图表和 170 页的访问。

内容

第 1 章调查方法及范围

  • 调查方法
  • 市场范围

第 2 章主要趋势和发展

第 3 章执行摘要

  • 按产品类型划分的市场细分
  • 按应用划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 促进因素
    • 抑制因素
    • 商机
  • 影响分析

第 5 章行业分析

  • 波特五力分析
  • 价值链分析
  • 专利分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措

第 7 章按产品类型

  • 设备和泵
  • 人体植入式输液泵
  • 胰岛素输液泵
  • 注射器式输液泵
  • 容积式输液泵
  • 肠内给药泵
  • 门诊输液泵
  • 其他

第 8 章按应用程序

  • 糖尿病专区
  • 化疗/肿瘤学
  • 肠胃科
  • 镇痛和疼痛管理
  • 儿科/新生儿科
  • 血液学
  • 其他

第 9 章最终用户

  • 医院和诊所
  • 门诊护理设施
  • 家庭医疗机构
  • 学术和研究机构

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 竞争场景
  • 竞争对手战略分析
  • 市场情况/份额分析
  • 併购分析

第 12 章公司简介

  • B. Braun
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Medtronic PLC
  • F. Hoffmann-La Roche Ltd.
  • Smiths Medical
  • Becton, Dickinson, and Company
  • Baxter International Inc
  • Terumo Corporation
  • Teleflex, Inc.
  • Mindray Medical International Limited
  • Fresenius Kabi

第 13 章 DataM

简介目录
Product Code: DMPH2889

Market Overview

Infusion Pumps Market is forecasted to reach at a CAGR of 9% during the forecast period (2022-2029).

Infusion pumps are medical devices that deliver fluids, such as nutrients and medications, into the patient's body in controlled amounts. Infusion pumps have widespread use in clinical settings such as hospitals, nursing homes, and the home. They offer several advantages over manual administration, such as delivering fluids in small quantities and delivering fluids at precisely programmed rates or automated intervals. They deliver nutrients or medications, such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. The global infusion pump market is growing due to several factors, such as the rising incidence of chronic diseases with an increasing geriatric population, growing demand for ambulatory infusion pumps, technological advancements in devices & accessories, and the increasing number of surgical procedures performed.

Market Dynamics: The rising incidences of chronic diseases drive the market growth

In the United States, about six in ten live with chronic diseases, like heart disease, cancer, stroke, or diabetes. According to the report published by the Centre for disease control and prevention in 2022, In the United States, around 37.3 million people have diabetes, which is around 11.3% of the United States population. Among these, 28.7 million people were diagnosed; including 28.5 million adults and 8.5 million people (23.0% of adults are undiagnosed). A total 96 million people aged 18 years or older have prediabetes, around 38% of the adult US population. 26.4 million People in the United States aged 65 years or older (48.8%) have prediabetes. Diabetes is the seventh leading cause of death in the United States. Also, coronary heart disorder is the most common type of heart disease in the United States, killing about 382,820 people in 2020. About 20.1 million adults age 20 and older have coronary heart disorder (about 7.2%). In 2020, about 2 in 10 deaths from CAD happened in adults less than 65 years old.

However, stringent regulations, product recalls, and the rising adoption of refurbished infusion pumps hinder the market's growth. For instance, on March 6th, 2020, BD recalled Alaris System infusion pumps. According to the FDA, this has been identified as the Class I recall, one of the most serious types of recall. The use of these devices may cause serious injuries or death. BD/Care Fusion 303 recalls the Alaris Infusion Pump System and Modules due to multiple system errors, software errors, and use-related errors.

Market Segmentation: The insulin infusion pumps segment is projected to be the dominant segment in the market during the forecast period.

By product, the infusion pumps market is segmented into pumps & devices & accessories & consumables.

The insulin infusion pumps segment is estimated to grow at the fastest CAGR during the forecast period. The insulin pump provides continuous delivery of short-acting insulin all day long. The insulin pump substitutes the need for long-acting insulin. An insulin pump also replaces the need for multiple daily injections with a continuous insulin infusion and improves your blood sugar levels. Insulin infusion pumps are made of Teflon or steel and attach to your skin with an adhesive patch. The pump's underside is a short, thin tube (cannula) inserted in the skin with a small needle housed within the cannula to deliver insulin into a layer of fatty tissue. The increasing regulatory approvals from the national governing bodies for insulin infusion pumps drive the global drug delivery infusion system market. For instance, in August 2021, Lilly's insulin lispro-aabc injection (Lyumjev) 100 units/mL was granted FDA approval to improve glycemic control in adults with type 1 and type 2 diabetes, including administration via continuous subcutaneous insulin infusion with an insulin pump. Insulin pumps are an important delivery option for people with diabetes.

Based on application, the infusion pumps market is segmented into diabetes, gastroenterology, chemotherapy/oncology, analgesia/pain management, hematology, pediatrics/neonatology, and others.

Among these, the diabetes segment is estimated to grow at the highest CAGR over the forecast period, owing to the rising prevalence of diabetes and increasing demand for insulin pumps to manage diabetes in-home care. The launch of a new product for diabetes is driving the global drug delivery infusion system market.

Geographical Penetration: North America is the dominating region during the forecast period.

North America dominated the global infusion pumps market and accounted for the largest market share in 2021, owing to the high adoption of specialty infusion pumps to treat chronic diseases, increasing prevalence of chronic diseases, rising geriatric population, and the presence of many large hospitals in the region. The huge number of insulin therapy in Canada is driving the North American drug delivery infusion system market. According to Statista, in 2021, around 7.3 percent of Canadians reported that they had been diagnosed by a health professional as having diabetes. The geographical expansion of leading injection and infusion systems manufacturers drives the North American infusion pumps market. The infusion system's launch is a key factor driving the North American drug delivery infusion system market. For instance, in August 2022, Baxter International Inc., a leader in innovative technology for medication delivery, announced U.S. Food and Drug Administration approval for its new Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software, representing Baxter's latest developments for infusion therapy. These syringe infusion pumps are typically used to precisely deliver small amounts of fluid at low rates, often in pediatric, neonatal or anesthesia care settings.

Competitive Landscape:

The global infusion pumps market is fragmented, with a large number of international and local players. Some of the market's major players include B. Braun, Medtronic Plc, F. Hoffmann-La Roche Ltd., Smiths Medical, Becton, Dickinson And Company, Baxter International Inc., Terumo Corporation, Teleflex, Inc., Mindray Medical International Limited, Fresenius Kabi, among others. The key players are adopting various growth strategies such as expansion, mergers & acquisitions, partnerships, product launches, and collaborations, contributing to the growth of the Infusion Pumps market globally. For instance, On February 27th, 2020, LTR Medical entered an exclusive distribution agreement with Woo Young Medical to distribute their new generation of elastomeric infusion technologies into the Australian market. Woo Young Medical is one of the global leaders in ambulatory infusion technology, based in Korea. Pictured here are Lee Rodne, CEO of LTR Medical, and Brian Cha, COO/President of Woo Young Medical. On February 24th, 2020, United Therapeutics Corporation and DEKA Research & Development Corp. received 510(k) clearance by the U.S. Food and Drug Administration (FDA) related to the Unity Subcutaneous Delivery System for Remodulin (treprostinil) Injection, also referred to as the Remunity™ pump, enabling United Therapeutics to launch the system using drug reservoirs that specialty pharmacies have prefilled. Also, In January 2020, Medtronic launched Efficio, a cloud-based data management software, for use with the SynchroMed II intrathecal drug delivery system. It enables clinicians to efficiently manage their targeted drug delivery pump practices to treat patients with chronic pain, cancer, and severe spasticity.

The global infusion pumps market report would provide an access to approximately 44 market data tables, 43 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End-User
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market impacting factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
  • 4.2. Impact analysis

5. Industry Analysis

  • 5.1. Porter's five forces analysis
  • 5.2. Value chain analysis
  • 5.3. Patent Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Product Type Segment
    • 7.1.2. Market attractiveness index, By Product Type Segment
  • 7.2. Devices & Pumps *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 7.3. Implantable Infusion Pumps
  • 7.4. Insulin Infusion Pumps
  • 7.5. Syringe Infusion Pumps
  • 7.6. Volumetric Infusion Pumps
  • 7.7. Enteral Infusion Pumps
  • 7.8. Ambulatory Infusion Pumps
  • 7.9. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Application Segment
    • 8.1.2. Market attractiveness index, By Application Segment
  • 8.2. Diabetes *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 8.3. Chemotherapy/Oncology
  • 8.4. Gastroenterology
  • 8.5. Analgesia/Pain Management
  • 8.6. Pediatrics/Neonatology
  • 8.7. Hematology
  • 8.8. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market size analysis, and y-o-y growth analysis (%), By End-User Segment
    • 9.1.2. Market attractiveness index, By End-User Segment
  • 9.2. Hospitals & Clinics *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory Care Settings
  • 9.4. Home Care Settings
  • 9.5. Academic & Research Institutes

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key region-specific dynamics
    • 10.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Rest of South America
  • 10.4. Europe
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.4.6.1. Germany
      • 10.4.6.2. U.K.
      • 10.4.6.3. France
      • 10.4.6.4. Spain
      • 10.4.6.5. Italy
      • 10.4.6.6. Rest of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive scenario
  • 11.2. Competitor strategy analysis
  • 11.3. Market positioning/share analysis
  • 11.4. Mergers and acquisitions analysis

12. Company Profiles

  • 12.1. B. Braun*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Medtronic PLC
  • 12.3. F. Hoffmann-La Roche Ltd.
  • 12.4. Smiths Medical
  • 12.5. Becton, Dickinson, and Company
  • 12.6. Baxter International Inc
  • 12.7. Terumo Corporation
  • 12.8. Teleflex, Inc.
  • 12.9. Mindray Medical International Limited
  • 12.10. Fresenius Kabi
  • List not Exhaustive*

13. DataM

  • 13.1. Appendix
  • 13.2. About us and services
  • 13.3. Contact us